Vertex announced the first stem cell-derived islet therapy is entering a phase 3 clinical trial for type 1 diabetes.
Source: Vertex launches pivotal trial for stem-cell derived islet therapy – Breakthrough T1D
Vertex announced the first stem cell-derived islet therapy is entering a phase 3 clinical trial for type 1 diabetes.
Source: Vertex launches pivotal trial for stem-cell derived islet therapy – Breakthrough T1D